Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of SYR-322 in an Ascending Dose Regimen in Healthy Male Subjects
alogliptin
SYR-322/CPH-002
Not available
Diabetes Mellitus, Type 2
Phase 1
 
Select supporting documents are N/A in English and as such are N/A for sharing at this time.
October 2014

Powered by ideaPoint, Inc.